Bioserve Biotechnologies Partners with BioMavericks Ltd. to Expand Presence in the UK market
27 September 2023
[Hyderabad, India, 27 September 2023] – Bioserve Biotechnologies (India) Private Limited, a leader in molecular biology products, is teaming up with BioMavericks Ltd., a UK-based company. This partnership will allow Bioserve to extend its m...
Bioserve India to sponsor webinar hosted by the Society of Fetal Medicine
15 September 2021
Hyderabad India – 15 September 2021: Bioserve Biotechnologies India Pvt. Ltd. (a 100% owned subsidiary of REPROCELL Inc) will sponsor a webinar series hosted by the Society of Fetal Medicine in September. The title of the webinar is “Geneti...
REPROCELL and Hanugen to custom manufacture clinical grade oligos for gene therapy
24 April 2019
REPROCELL India (formerly BioServe Biotechnologies India Pvt Ltd) and Hanugen Therapeutics have announced the launch of their custom manufacture offering for synthesis of milli molar scale clinical grade oligonucleotides for gene therapy. A...
REPROCELL USA Inc. Achieves Quality Management ISO9001:2015 Certification
08 April 2019
See the press release on PRWeb: REPROCELL USA Inc. Achieves Quality Management ISO9001:2015 Certification REPROCELL USA has achieved ISO9001:2015 accreditation for quality management utilizing the standard operating protocols established ov...
REPROCELL’s footprint extends to serve life sciences in India
13 June 2018
REPROCELL India (formerly BioServe Biotechnologies) is a state-of-the-art biotechnology company with a mission to serve the life sciences research ecosystem. BioServe Biotechnologies (India) has been a pioneer commercial laboratory that beg...
Acquisition of BioServe Biotechnologies India Pvt. Ltd.
26 April 2018
REPROCELL announces that it has acquired all the shares of BioServe Biotechnologies India Pvt. Ltd., (Hyderabad, India hereinafter referred to as “BioServe India”) from Cancer Genetics Inc. (USA). Bioserve India now becomes a subsidiary of ...